Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal

5 Effect of composite nanoparticles on HCV infection in Huh7.5.1 cells: HCV replicating cells were propagated in complete medium supplemented with 1% DMSO to slow down

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.. All

Intervention: HCV RNA testing at the time of receipt of a positive HCV antibody result Comparison: HCV RNA test in the context of HCV care as part of assessment for HCV therapy

Among the HCV-Ab positive samples, 15 patients had documented chronic HCV infection and presented a detectable HCV RNA and 4 patients had documented acute

Using dihydroethidium (DHE) as a marker for intracellular ROS, we found that hepatocyte-specific ROS levels were significantly higher in frozen liver sections from

Methods: A Markov model simulated chronic hepatitis C (CHC) prevalence, incidence of events, quality adjusted life years (QALYs), costs and incremental cost-effectiveness ratio

HCV RNA values on DBS specimens were compared to serum HCV RNA values quantified in matched serum samples collected in 37 HCV-infected patients followed in the Montpellier

Adopting a health sector perspective in Cameroon, Cote-d’Ivoire, and Senegal, a decision tree model was developed to compare 12 testing strategies with the following characteris-